Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue. 1996

V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
Institut für Pathologie, Universität Würzburg, Germany.

We analysed the proliferative activity of synovial lining cells (SLCs), the distribution of proliferating B and T lymphocytes and the relationship of proliferating B and T lymphocytes to the pattern of antigen-presenting cells (APCs) within the rheumatoid synovial tissue (n = 21). The immunohistochemical detection of the proliferation-associated antigen Ki67 revealed low proliferative activity of SCL with and without expression of the Kim 8 (CD68) antigen. Ki67-positive B lymphocytes could be observed within secondary follicles (2/21), in small follicular dendritic reticulum cell (FDC)-containing follicle-like aggregates (7/21) and near the enlarged synovial intima (6/21). Ki67-positive T lymphocytes could be detected in T-lymphocyte aggregates (8/21), in the vicinity of blood vessels (18/21) and within the enlarged synovial intima (15/21). Semiquantitative analysis showed a strong correlation between the numbers of Ki67-positive B lymphocytes and FDCs and between the numbers of Ki67-positive T lymphocytes and interdigitating dendritic reticulum cells (IDC). There were significant differences in the number of Ki 67-positive B and T lymphocytes, IDCs and FDCs between the two groups of rheumatoid arthritis (RA) patients with different local clinical activity. These findings demonstrate a low proliferation of SLCs with and without expression of the monocyte-specific antigen Kim 8 and imply that B and T lymphocyte proliferation occurs in the presence of FDCs and IDCs. These results indicate that the RA synovial tissue is a site for antigen-dependent proliferation and maturation of B and T lymphocytes. The atypical pattern of FDC distribution within the rheumatoid synovial tissue "dysmorphic follicle" may be regarded as morphological substrate for a dysmaturation compartment of B lymphocytes leading to pathogenetic autoimmune phenomena in RA patients.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
June 1994, Immunology,
V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
January 1996, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
July 1981, Arthritis and rheumatism,
V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
October 1992, Human immunology,
V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
May 1993, Clinical and experimental immunology,
V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
July 1993, Cancer,
V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
December 1999, Bailliere's best practice & research. Clinical rheumatology,
V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
February 1989, Transplantation proceedings,
V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
January 1998, Springer seminars in immunopathology,
V Krenn, and N Schalhorn, and A Greiner, and R Molitoris, and A König, and F Gohlke, and H K Müller-Hermelink
May 1977, Clinical and experimental immunology,
Copied contents to your clipboard!